orthotop transplant patient hepat virus-rel liver diseas fifty-nin patient prior hepat viru infect underw orthotop liver transplant first mo mortal differ hepat virus-infect group hepat virus-immun control group mo mortal rate graft loss retransplant incid abnorm liver function hepat virus-infect group treatment hepat viru infect passiv immun activ passiv immun alpha-interferon noth clinic outcom therapi patient day treat activ passiv immun hbsag someth patient alpha-interferon patient passiv immun patient therapi patient recurr hepat viru infect pace hepat develop graft strike patient multipl retransplant shorter interv none patient hbsag-neg hbeag 